Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events

    New study shows Aurase wound gel enables painless debridement of chronic wounds

    Peer-reviewed paper highlights pain-free enzymatic approach for venous leg ulcers [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    BiomX’s BX004 slashes antibiotic-resistant bacteria in landmark cystic fibrosis study

    Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    AI validation of rentosertib efficacy supports global trial expansion in IPF

    Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

    May 5, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    OMED Health launches new gastrointestinal treatments and services through personalized health plans

    OMED Health, a UK-based company developing non-invasive breath analysis tools [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory

    Nanoscope Therapeutics begins FDA submission for gene-agnostic therapy to treat retinitis pigmentosa

    Nanoscope Therapeutics has initiated a rolling submission for its Biologics [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    NICE recommends Mirikizumab for moderately to severely active Crohn’s Disease after biologic failure

    Mirikizumab is now recommended by NICE for routine NHS use [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    SPT Labtech and Semarion join forces to automate and miniaturize cell-based assays

    SPT Labtech has partnered with Semarion to integrate its firefly [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    How nurse practitioners and physician associates are transforming healthcare access

    As healthcare delivery evolves – especially in rural and underserved [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    VIVES Partners joins Nuclidium AG’s €84M Series B Financing to advance copper-based radiopharmaceuticals

    VIVES Partners, managing company of VIVES Funds, has joined a [...]

    May 5, 2026
Previous666768Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ViiV Healthcare HIV regimen Dovato non-inferior to Biktarvy in Phase 3b study
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Seegene data finds STI pathogens in 82% of HPV-positive test results
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development
  • AI-driven antibody discovery could create $7bn market for life science tools
    Categories: Digital & Data, Drug Delivery & Formulation, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top